Health professionals are encouraged to take the ESC Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

Despite optimal combination of guideline-directed anti-ischemic therapies and myocardial
revascularization, a substantial proportion of patients with stable coronary artery disease …

Objectives This study investigated the prognosis of coronary microvascular disease (CMD)
as determined by stress perfusion cardiac magnetic resonance (CMR) in patients with …

Background Angina might persist or reoccur despite successful revascularisation with
percutaneous coronary intervention (PCI) and antianginal therapy. Additionally, PCI in …

Objectives The present study aimed to assess the feasibility and clinical value of
acetylcholine (ACh) rechallenge for the detection of coexisting epicardial and microvascular …

Ischaemic heart disease is a major cause of death and disability worldwide, while angina
represents its most common symptom. It is estimated that approximately 9 million patients in …

In patients with chronic obstructive pulmonary disease (COPD), cardiovascular
comorbidities are highly prevalent and associated with considerable morbidity and mortality …

Despite the use of anti-anginal drugs and/or percutaneous coronary interventions (PCI) or
coronary artery bypass grafting, the proportion of patients with coronary artery disease who …

Management of stable coronary artery disease (CAD) has been based on the assumption
that flow-limiting atherosclerotic obstructions are the proximate cause of angina and …

Background: Although angina is common in patients with stable coronary artery disease,
limited data are available on its prevalence, natural evolution, and outcomes in the era of …